After 27 fatalities, the destruction of over 12,000 structures, and $150 to $250 billion in damages, California resident and comedian Bill Maher didn’t hold back his outrage over his state’s catastrophic wildfire response on Real Time.
In a scathing monologue, Maher first pointed out to the climate cult that mandating EVs and shaming people for their carbon footprints means nothing when the government can’t even manage wildfires.
“You know what the absolute worst thing for the environment is? Wildfires. A 2022 study found that the smoke from just the two in 2020 wiped out 18 years of carbon reduction in the state—which means we suffered the pain of driving those early-model Priuses for nothing,” Maher quipped.
Join 100K+ Substack readers and 1.5 million 𝕏 users who follow the work of Vigilant Fox. Subscribe to Vigilant News for exclusive stories you won’t find anywhere else.
Maher zeroed in on LA Mayor Karen Bass’s selection of Kristin Crowley as fire chief, suggesting she was only chosen for being the “best lesbian” for the job instead of the best person—something Maher argued was “not good enough” for essential services.
“Am I against a lesbian being chief? Of course not. Do I think a lesbian can do the job? Of course, I do. And maybe she’s the best person for the job. Or maybe they really wanted a lesbian in that job, and she’s just the best lesbian for the job, and with essential services, that’s not good enough,” Maher snapped.
“Crowley’s official bio says, ‘Chief Crowley leads a diverse department, creating, supporting, and promoting a culture that values diversity, inclusion, and equity, while striving to meet and exceed the expectations of the communities.’ Well, you didn’t exceed my expectations, which was that the whole city wouldn’t burn down!” he stressed.
“But it’s telling that diversity is mentioned twice before we get to ‘while striving to meet expectations.’ Now, can you do two things at once? Yes, but it matters where your head is,” Maher argued.
Maher went on to admit that it’s “not wrong” to blame wokeness for California’s disastrous fire response, turning his attention to Deputy Fire Chief Kristine Larson, whose recent comments are so absurd that Maher called them “kind of racist.”
Larson said in a viral social media post, “You want to see somebody that responds to your house, your emergency, whether it’s a medical call or a fire call that looks like you.”
Maher fired back at this statement, saying, “which would sound kind of racist if a Southern sheriff said it.”
“Now, is wokeness the main reason for the fires? Of course not,” Maher said. “But let’s not pretend it hasn’t played a role. Our government’s unforced errors are straight out of the progressive playbook: questionable budget priorities, sky-high taxes that get you nothing, and a constant obsession with identity politics instead of fixing what’s broken.”
“Cali’s got commissions, agencies, bureaucrats, and even sign language interpreters who emote with their face,” Maher continued. “But where’s the common sense? Where’s the action?” he asked.
In his final words, Maher warned California that they better figure out how to actually govern “soon” because “wildfires in California are like boob jobs in a strip club: inevitable, and only getting bigger.”
Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.
The FDA old guard criticized the new leadership in a Dec. 3 New England Journal of Medicine (NEJM) letter over a higher regulatory bar for vaccines, namely the expectation that most new vaccine approvals will require randomized clinical trials, arguing it could hamper the market.
“Insisting on long, expensive outcomes studies for every updated formulation would delay the arrival of better-matched vaccines when new outbreaks emerge or when additional groups of patients could benefit,” the former commissioners wrote. “Abandoning the existing methods won’t ‘elevate vaccine science’ … It will subject vaccines to a substantially higher and more subjective approval bar.”
But while the former commissioners disclosed their conflicts of interest to the medical journal — per standard practice in scientific publishing — reporters didn’t relay them to the broader public in reports in the Washington Post, STAT News and CNN.
The headlines about a bipartisan rebuke from former occupants of FDA’s highest office give the impression that the Trump administration is contravening established science, but closer inspection reveals a revolving door between pharmaceutical corporations and the agencies overseeing them.
Three of the signatories have received payments totaling $6 million from manufacturers or former manufacturers of COVID vaccines.
Scott Gottlieb has received $2.1 million in cash and stock from his position on the Pfizer board of directors, where he has advised on ethics and regulatory compliance since 2019, according to company filings to the Securities and Exchange Commission. Stephen Ostroff has received $752,310 from Pfizer in consulting fees since 2020, according to OpenPayments.
Gottlieb and McClellan did not respond to requests for comment. Ostroff could not be reached for comment.
FDA Center for Biologics Evaluation and Research Director Vinay Prasad outlined the higher standards and shared the results of an internal analysis validating 10 reports of children’s deaths following the COVID-19 vaccine in a Nov. 28 memo to staff. He called for introspection and reform at the agency.
The NEJM letter criticizes Prasad for cracking down on a practice called “immunobridging” that infers vaccine efficacy from laboratory tests rather than assessing it through real-world reductions in disease or death. The FDA under the Biden administration expanded COVID vaccines to children using this “immunobridging” technique, extrapolating vaccine efficacy from adults to children based on antibody levels.
Norman Sharpless — who in addition to previously serving as acting FDA commissioner also served as the head of the National Institutes of Health’s National Cancer Institute — consults for Tempus, a company that collaborates with COVID vaccine maker BioNTech. He has helped steer $70 million in investments in biotech through a venture capital firm he founded in November 2024. Sharpless also disclosed $26,180 in payments in 2024 from Chugai Pharmaceutical, a Japanese pharmaceutical company that markets mRNA technology among other drugs, on OpenPayments.
“I was grateful for the opportunity to serve as NCI Director and Acting FDA Commissioner in the first Trump Administration, and strongly support many of the things President Trump is trying to do in the current Administration,” Sharpless said in an email.
Margaret Hamburg, another former FDA commissioner and signatory of the NEJM letter, has since 2020 earned $2.8 million as a member of the board of Alnylam Pharmaceuticals, which markets RNA interference (RNAi) technology.
Hamburg did not respond to a message on LinkedIn.
Most signatories disclosed income from biotech companies testing experimental cancer treatments. These products could face tighter scrutiny under Prasad, a hematologist-oncologist long wary of rubberstamping pricey oncology drugs — which Prasad points out often cause some toxicity — without plausible evidence of an improvement in quality of life or survival.
The former FDA commissioners disclosed ties to Sermonix Pharmaceuticals Inc.; OncoNano Medicine; incyclix; Nucleus Radiopharma; and N-Power, a contractor that runs oncology clinical trials.
Andrew von Eschenbach, who like Sharpless formerly served both as FDA commissioner and the head of the National Cancer Institute, disclosed stock in HistoSonics, a company with investments from Bezos Expeditions and Thiel Bio seeking FDA approval for ultrasound technology targeted at tumors.
Some FDA commissioners who signed onto the letter opposing changes to vaccine approvals have ties to biotechnology investment firms, namely McClellan, who consults Arsenal Capital; Janet Woodcock, who consults RA Capital Management; and Robert Califf, who owns stock in Population Health Partners.
Califf did not respond to an email requesting comment. Woodcock did not respond to requests for comment sent to two medical research advocacy groups with Woodcock on the board. Eschenbach did not respond to a LinkedIn message.
The two signatories without pharmaceutical ties may find their judgement challenged by the FDA investigation into COVID-19 vaccine deaths, having either implemented or formally defended the Biden administration’s headlong expansion of vaccines and boosters to healthy adults and children.
David Kessler executed Biden’s vaccination policy as chief science officer at the Department of Health and Human Services, helping to secure deals for shotswith Pfizer and Moderna.
Meanwhile Jane Henney chaired a National Academies of Sciences, Engineering, and Medicine report published in October 2025 that praised the performance of FDA and Centers for Disease Control and Prevention (CDC) vaccine surveillance during the pandemic — underwritten with CDC funding.
That assessment clashes with that of a Senate report, citing internal documents from FDA, finding that CDC never updated its vaccine surveillance tool “V-Safe” to include cardiac symptoms, despite naming myocarditis as a potential adverse event by October 2020, and that top officials in the Biden administration delayed warning pediatricians and other providers about the risk of myocarditis after their approval in some children in May 2021, months after Israeli health officials first detected it in February 2021. The Senate investigation named Woodcock, a signatory of the NEJM letter, as one of the FDA officials who slow-walked the warning.
The U.S. Department of Justice will not release the entirety of the federal government’s files on sex trafficker Jeffrey Epstein by the end of day Friday, failing to fully comply with a mandate from Congress.
DOJ will release several hundred thousand documents, however, Deputy Attorney General Todd Blanche said in a Fox News interview. He estimated that “several hundred thousand more” will be released “over the next couple of weeks.”
The delay, Blanche explained, is due to the significant number of redactions that the department must complete in order to protect the identifications of witnesses and victims in the files.
By failing to fully comply with a congressional edict, lawmakers would have grounds to impeach or hold U.S. Attorney General Pam Bondi in contempt of Congress.
Congress passed the Epstein Files Transparency Act on Nov. 18, which President Donald Trump signed into law the next day.
The bill, sponsored by Reps. Ro Khanna, D-Calif.; and Thomas Massie, R-Ky., requires that the U.S. Attorney General “make publicly available in a searchable and downloadable format all unclassified records, documents, communications, and investigative materials in the possession of the Department of Justice” that relate to Epstein and his close associate Ghislaine Maxwell.
“Any Justice Department official who does not comply with this law will be subject to prosecution for obstruction of justice,” Khanna vowed.
Epstein died in jail awaiting trial in 2019 and Maxwell is currently serving a 20-year prison sentence.
President Donald Trump, former president Bill Clinton, billionaire businessman Bill Gates, and dozens of other high-profile figures have received intense public scrutiny for their connections with Epstein and Maxwell.
